Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 13;13:854764. doi: 10.3389/fgene.2022.854764

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Najar, Arefian, Sidransky, Gowda, Prasad, Modi and Chatterjee.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Inhibition of CAMKK2 results in change in tyrosine phosphoproteome in gastric cancer cells. (A) Bar graph summarizes phospho-Y-proteomic changes in gastric cancer cells (AGS) treated with 18.5 μM STO-609 and vehicle control. (B) Principal component analysis of control and CAMKK2-inhibited AGS cells. (C) Volcano plot showing the distribution of phosphopeptides upon STO-609 treatment 18.5 µM for 2 h. (D) Box plot showing the sum of protein abundances between the control and STO-609–treated AGS cells across the triplicates. (E) Box plot showing the sum of peptides abundances between the control and STO-609–treated AGS cells across the triplicates. (F) The bar graph shows the q-value of peptides.